Journal of internal medicine · 2017 · DOI
This guideline establishes internationally agreed-upon criteria for diagnosing ME/CFS, helping doctors around the world recognize the condition consistently. It brings together expert knowledge to create clear standards for who has ME/CFS based on symptoms like post-exertional malaise (worsening after activity), sleep problems, cognitive difficulties, and pain. Having a shared definition makes it easier for patients to get accurate diagnoses and for researchers to study the same condition across different countries.
Standardized diagnostic criteria are essential for reducing diagnostic delays and ensuring patients receive consistent recognition of their illness across different healthcare systems and countries. This guideline enables researchers to compare studies meaningfully and accelerates understanding of ME/CFS pathophysiology by ensuring all participants meet the same diagnostic threshold.
This guideline does not establish the underlying biological causes of ME/CFS or identify biomarkers that could confirm diagnosis through objective testing. It describes what doctors should observe clinically but does not provide evidence that any single cause or mechanism produces these symptoms.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →